Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Apr 5, 2011 (rev. 1)

Premium

Abbott Molecular has launched its CE-Marked Abbott HBV Sequencing test in the European Union. The test is the first sequencing-based diagnostic to be developed by Abbott, and was developed on Life Technologies' CE 3130 DNA sequencing system.

According to the company, the test identifies the DNA sequence of the hepatitis B virus polymerase gene, including all clinically relevant HBV drug resistant mutations.

This molecular diagnostic test was developed to help physicians monitor HBV infections, guide treatment decisions, and predict or discover drug resistance. It is not intended for screening blood donors, plasma, or tissue donors for HBV, or to be used as a diagnostic test to confirm the presence of HBV infection, Abbott said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more